Alnylam Pharmaceuticals (ALNY) Earnings Date, Estimates & Call Transcripts $311.92 +3.21 (+1.04%) As of 10:17 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Alnylam Pharmaceuticals Earnings Summary Alnylam Pharmaceuticals released Q1 2025 earnings on May 1, 2025, reporting an EPS of -$0.44, which missed the consensus estimate of -$0.37 by $0.07. Quarterly revenue rose 20.2% year-over-year to $594.19 million, above analyst estimates of $584.32 million. With a trailing EPS of -$2.09, Alnylam Pharmaceuticals' earnings are expected to grow next year, from ($1.70) to $0.89 per share. Upcoming Q2 Earnings DateJul. 30Before Market OpensEstimatedConsensus EPS (May. 1) -$0.37 Actual EPS (May. 1) -$0.44 Missed By -$0.07 Actual Revenue (May. 1) $594.19MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q) Slide DeckSEC FilingALNY Upcoming EarningsAlnylam Pharmaceuticals' next earnings date is estimated for Wednesday, July 30, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Alnylam Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alnylam Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataALNY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ALNY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Alnylam Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20254-$1.00-$0.67-$0.79Q2 20254-$0.74-$0.56-$0.62Q3 20254-$0.64$0.15-$0.35Q4 20254-$0.42$0.50-$0.00 FY 2025 16 -$2.80 -$0.58 -$1.76 Q1 20261-$0.05-$0.05-$0.05Q2 20261-$0.15-$0.15-$0.15Q3 20261$0.07$0.07$0.07Q4 20261-$0.08-$0.08-$0.08 Alnylam Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)--------5/1/2025Q1 2025-$0.37-$0.44 -$0.07-$0.44$584.32M$594.19M2/13/2025Q4 2024-$0.62-$0.65 -$0.03-$0.65$580.62M-10/31/2024Q3 2024-$0.51-$0.87 -$0.36-$0.87$532.91M$500.90M8/1/2024Q2 2024-$0.74-$0.13+$0.61-$0.13$447.22M$659.83M5/2/2024Q1 2024-$0.75-$0.52+$0.23-$0.52$428.01M$494.33M2/15/2024Q4 2023-$1.20-$1.10+$0.10-$1.10$439.38M$439.72M11/2/2023Q3 2023-$1.61$1.15+$2.76$1.15$406.14M$750.53M8/3/2023Q2 2023-$1.72-$2.21 -$0.49-$2.21$331.73M$318.75M Alnylam Pharmaceuticals Earnings - Frequently Asked Questions When is Alnylam Pharmaceuticals' earnings date? Alnylam Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on ALNY's earnings history. What guidance has Alnylam Pharmaceuticals issued on next quarter's earnings? Alnylam Pharmaceuticals updated its FY 2025 earnings guidance on Thursday, May, 1st. The company issued revenue guidance of $2.7 billion-$3.0 billion, compared to the consensus revenue estimate of $2.9 billion. Did Alnylam Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Alnylam Pharmaceuticals (NASDAQ:ALNY) missed the analysts' consensus estimate of ($0.37) by $0.07 with a reported earnings per share (EPS) of ($0.44). Learn more on analysts' earnings estimate vs. ALNY's actual earnings. How can I listen to Alnylam Pharmaceuticals' earnings conference call? The conference call for Alnylam Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read Alnylam Pharmaceuticals' conference call transcript? The conference call transcript for Alnylam Pharmaceuticals' latest earnings report can be read online. Read Transcript How can I view Alnylam Pharmaceuticals' earnings report? Alnylam Pharmaceuticals' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Alnylam Pharmaceuticals generate each year? Alnylam Pharmaceuticals (NASDAQ:ALNY) has a recorded annual revenue of $2.25 billion. How much profit does Alnylam Pharmaceuticals generate each year? Alnylam Pharmaceuticals (NASDAQ:ALNY) has a recorded net income of -$278.16 million. ALNY has generated -$2.09 earnings per share over the last four quarters. What is Alnylam Pharmaceuticals' EPS forecast for next year? Alnylam Pharmaceuticals' earnings are expected to grow from ($1.70) per share to $0.89 per share in the next year. More Earnings Resources from MarketBeat Related Companies Amgen Earnings Date Gilead Sciences Earnings Date Vertex Pharmaceuticals Earnings Date Regeneron Pharmaceuticals Earnings Date Biogen Earnings Date Incyte Earnings Date United Therapeutics Earnings Date Neurocrine Biosciences Earnings Date Exelixis Earnings Date BioMarin Pharmaceutical Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:ALNY) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored72 Hours Until Musk’s $34 Trillion AI Network BeginsIn just 72 hours, Elon Musk is expected to flip the switch on Tesla’s autonomous network in Austin, Texas. ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | SponsoredGold Just Jumped Again. Here’s How to Get PaidGold prices just spiked again. As I write this, gold is trading near $3,400 an ounce. But here's the thi...Investors Alley | SponsoredThe Dollar Reset Nobody’s Talking AboutCould this man take down the financial system? In March, the Senate granted sweeping powers to a Harvard ec...Stansberry Research | SponsoredBREAKING: Trump vs. Elon Feud Threatens Your Retirement – Protect Yourself NOW"This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump a...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALNY Stock Free ALNY Stock Alerts